{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:05:07Z","timestamp":1782997507013,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10072-013-1323-y","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T04:06:04Z","timestamp":1360123564000},"page":"1735-1744","source":"Crossref","is-referenced-by-count":1,"title":["Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions"],"prefix":"10.1007","volume":"34","author":[{"given":"Rumi","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Imamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iku","family":"Utsnomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumasa","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DB Drachman","year":"1994","unstructured":"Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"1323_CR2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/273469a0","volume":"273","author":"S Bevan","year":"1978","unstructured":"Bevan S, Kullberg RW, Rice J (1978) Acetylcholine-induced conductance fluctuations in cultured human myotubes. Nature 273:469\u2013471","journal-title":"Nature"},{"key":"1323_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02000612","volume":"76","author":"G Goldberg","year":"1983","unstructured":"Goldberg G, Mochly-Rosen D, Fuchs S, Lass Y (1983) Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs. J Membr Biol 76:123\u2013128","journal-title":"J Membr Biol"},{"key":"1323_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1113\/jphysiol.1989.sp017573","volume":"411","author":"RA Maselli","year":"1989","unstructured":"Maselli RA, Nelson DJ, Richman DP (1989) Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate. J Physiol 411:271\u2013283","journal-title":"J Physiol"},{"key":"1323_CR5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.410430408","volume":"43","author":"J Bufler","year":"1998","unstructured":"Bufler J, Pitz R, Czep M, Wick M, Franke C (1998) Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels. Ann Neurol 43:458\u2013464","journal-title":"Ann Neurol"},{"key":"1323_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.1996.sp021293","volume":"411","author":"J Bufler","year":"1996","unstructured":"Bufler J, Kahlert S, Tzartos S, Toyka KV, Maelicke A, Franke C (1996) Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the biding site of the acetylcholine receptor. J Physiol 411:107\u2013114","journal-title":"J Physiol"},{"key":"1323_CR7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357:2122\u20132128","journal-title":"Lancet"},{"key":"1323_CR8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/pgmj.61.718.725","volume":"61","author":"AK Mier","year":"1985","unstructured":"Mier AK, Havard CW (1985) Diaphragmatic myasthenia in mother and child. Postgraduate Med J 61:725\u2013727","journal-title":"Postgraduate Med J"},{"key":"1323_CR9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis. Brain 131:1940\u20131952","journal-title":"Brain"},{"key":"1323_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","volume":"85","author":"TM DeChiara","year":"1996","unstructured":"DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501\u2013512","journal-title":"Cell"},{"key":"1323_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","volume":"85","author":"DJ Glass","year":"1996","unstructured":"Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM, Yancopoulos GD (1996) Agrin acts via a MuSK receptor complex. Cell 85:513\u2013523","journal-title":"Cell"},{"key":"1323_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2004-829589","volume":"24","author":"A Vincent","year":"2004","unstructured":"Vincent A, McConville J, Farrugia ME, Newsom-Davis J (2004) Seronegative myasthenia gravis. Semin Neurol 24:125\u2013133","journal-title":"Semin Neurol"},{"key":"1323_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"1323_CR14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.clinph.2006.03.028","volume":"117","author":"A Rostedt Punga","year":"2006","unstructured":"Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A, Kalimo H, Stalberg EV (2006) Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 117:1434\u20131443","journal-title":"Clin Neurophysiol"},{"key":"1323_CR15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainres.2004.11.057","volume":"1034","author":"K Taguchi","year":"2005","unstructured":"Taguchi K, Shiina M, Shibata K, Utsunomiya I, Miyatake T (2005) Spontaneous muscle action potentials are blocked by N-type and P\/Q-type calcium channels blockers in the rat spinal cord-muscle co-culture system. Brain Res 1034:62\u201370","journal-title":"Brain Res"},{"key":"1323_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2004.07.011","volume":"225","author":"K Taguchi","year":"2004","unstructured":"Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H (2004) Neurophysiological and immunohistochemical studies on Guillan-Barr\u00e9 syndrome with IgG anti-GalNAc-GD1a antibodies\u2014Effects on neuromuscular transmission. J Neurol Sci 225:91\u201398","journal-title":"J Neurol Sci"},{"key":"1323_CR17","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1212\/WNL.38.12.1890","volume":"38","author":"M Schluep","year":"1988","unstructured":"Schluep M, Steck AJ (1988) Immunostaining of motor neuron terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 38:1890\u20131892","journal-title":"Neurology"},{"key":"1323_CR18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00374570","volume":"428","author":"R Barret-Jolley","year":"1994","unstructured":"Barret-Jolley R, Byrne N, Vincent A, Newsom-Davis J (1994) Plasma from patients with seronegative myasthenia gravis inhibits nAChR responses in the TE671\/RD cell line. Pflugers Arch 428:492\u2013498","journal-title":"Pflugers Arch"},{"key":"1323_CR19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.54.2.474","volume":"54","author":"K Jahn","year":"2000","unstructured":"Jahn K, Franke C, Bufler J (2000) Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seronegative patients with myasthenia gravis without acetylcholine receptor antibodies. Neurology 54:474\u2013479","journal-title":"Neurology"},{"key":"1323_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-5728(88)90043-4","volume":"19","author":"B Lang","year":"1988","unstructured":"Lang B, Richardson G, Rees J, Vincent A, Newsom-Davis J (1988) Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell lines. J Neuroimmunol 19:141\u2013148","journal-title":"J Neuroimmunol"},{"key":"1323_CR21","first-page":"751","volume":"133","author":"SP Ringel","year":"1988","unstructured":"Ringel SP, Bender AN, Engel WK (1988) Extrajunctional acetylcholine receptors. Alterations in human and experimental neuromuscular diseases. Arch Neurol 133:751\u2013758","journal-title":"Arch Neurol"},{"key":"1323_CR22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1152\/physrev.1984.64.4.1162","volume":"64","author":"JL Popot","year":"1984","unstructured":"Popot JL, Changeux JP (1984) Nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein. Physiol Rev 64:1162\u20131239","journal-title":"Physiol Rev"},{"key":"1323_CR23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/321406a0","volume":"321","author":"M Mishina","year":"1986","unstructured":"Mishina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C, Sakmann B (1986) Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321:406\u2013411","journal-title":"Nature"},{"key":"1323_CR24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","volume":"185","author":"ME Farrugia","year":"2007","unstructured":"Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A (2007) Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 185:136\u2013144","journal-title":"J Neuroimmunol"},{"key":"1323_CR25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1073\/pnas.76.1.504","volume":"76","author":"CB Weinberg","year":"1979","unstructured":"Weinberg CB, Hall ZW (1979) Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. PNAS 76:504\u2013508","journal-title":"PNAS"},{"key":"1323_CR26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1139\/y80-076","volume":"58","author":"UR Tipnis","year":"1980","unstructured":"Tipnis UR, Malhotra SK (1980) Junctional and extrajunctional acetylcholine receptors. Can J Physiol Pharmacol 58:445\u2013458","journal-title":"Can J Physiol Pharmacol"},{"key":"1323_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0005-2795(75)90217-2","volume":"393","author":"RR Almon","year":"1975","unstructured":"Almon RR, Appel SH (1975) Interaction of myasthenic serum globulin with acetylcholine receptor. Biochim Biophys Acta 393:66\u201377","journal-title":"Biochim Biophys Acta"},{"key":"1323_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/269218a0","volume":"269","author":"JA Freeman","year":"1977","unstructured":"Freeman JA (1977) Possible regulatory function of acetylcholine receptor in maintenance of retinotectal synapses. Nature 269:218\u2013222","journal-title":"Nature"},{"key":"1323_CR29","first-page":"981","volume":"43","author":"Q Yi","year":"1996","unstructured":"Yi Q, Pirskanen R, Lefvert AK (1996) Presynaptic membrane receptor-reactive T lymphocytes in myasthenia gravis. Scand J Immunol 43:981\u2013987","journal-title":"Scand J Immunol"},{"key":"1323_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(91)90091-K","volume":"102","author":"CZ Lu","year":"1991","unstructured":"Lu CZ, Link H, Mo XA, Xiao BG, Zhang YL, Qin Z (1991) Anti-presynaptic membrane receptor antibodies in myasthenia gravis. J Neurol Sci 102:39\u201345","journal-title":"J Neurol Sci"},{"key":"1323_CR31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90085-D","volume":"43","author":"CZ Lu","year":"1993","unstructured":"Lu CZ, Lu L, Hao ZS, Xia DG, Qain J, Arnason BG (1993) Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. J Neuroimmunol 43:145\u2013149","journal-title":"J Neuroimmunol"},{"key":"1323_CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-510X(95)00017-V","volume":"130","author":"Y Shi","year":"1995","unstructured":"Shi Y, Xu Y, Xu K (1995) Selective inhibition of the slow K+ current at motor nerve ending by plasma from a myasthenia gravis patient. J Neurol Sci 130:165\u2013170","journal-title":"J Neurol Sci"},{"key":"1323_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1179\/016164103101200932","volume":"25","author":"TH Xu","year":"2003","unstructured":"Xu TH, Ding J, Shi YL, Li MF, Li CZ, Qiao J (2003) Effects of myasthenia gravis patients\u2019 sera with different autoantibodies on slow K+ current at mouse motor nerve terminals. Neurol Res 25:58\u201362","journal-title":"Neurol Res"},{"key":"1323_CR34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-5728(95)00169-7","volume":"64","author":"Z Li","year":"1996","unstructured":"Li Z, Forester N, Vincent A (1996) Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis. J Neuroimmunol 64:179\u2013183","journal-title":"J Neuroimmunol"},{"key":"1323_CR35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","volume":"47","author":"F Blaes","year":"2000","unstructured":"Blaes F, Beeson D, Plested P, Lang B, Vincent A (2000) IgG from \u201cseronegative\u201d myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann Neurol 47:504\u2013510","journal-title":"Ann Neurol"},{"key":"1323_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","volume":"1132","author":"A Vincent","year":"2008","unstructured":"Vincent A, Leite MI, Farrugia ME, Jacob S, Viegas S, Shiraishi H, Benveniste O, Morgan BP, Hilton-Jones D, Newsom-Davis J, Beeson D, Willcox N (2008) Myasthenia gravis seronegative for acetylcholine receptor antibodies. Ann N Y Acad Sci 1132:84\u201392","journal-title":"Ann N Y Acad Sci"},{"key":"1323_CR37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","volume":"259","author":"A Pevzner","year":"2011","unstructured":"Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kr\u00f6ger S (2011) Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259:427\u2013435. doi: 10.1007\/s00415-011-6194-7","journal-title":"J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1323-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1323-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1323-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T05:38:50Z","timestamp":1562650730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1323-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1323-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}